Abstract
The present study describes the distribution of Leu M1 (CD15) immunoreactivity in 13 normal epithelia and 14 epithelial neoplasms. The findings are compared with those obtained using other epithelial markers. Cautionary points and broad recommendations are made with regard to use of anti Leu M1 antibody.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have